Pharmacokinetics of liposome-encapsulated anti-tumor drugs. Studies with vinblastine, actinomycin D, cytosine arabinoside, and daunomycin.
D000818:Animals; D003561:Cytarabine / Q000008:administration & dosage / Q000378:metabolism*; D003609:Dactinomycin / Q000008:administration & dosage / Q000378:metabolism*; D003630:Daunorubicin / Q000008:administration & dosage / Q000378:metabolism*; D004355:Drug Stability; D007700:Kinetics; D008081:Liposomes / Q000378:metabolism*; D008297:Male; D014677:Pharmaceutical Vehicles; D051381:Rats; D014018:Tissue Distribution; D014747:Vinblastine / Q000008:administration & dosage / Q000378:metabolism*
D008081:Liposomes; D014677:Pharmaceutical Vehicles; D003561:Cytarabine; D003609:Dactinomycin; D014747:Vinblastine; D003630:Daunorubicin